External Post-Operative Skull Prosthesis to Prevent Sunken Flap Syndrome in Craniectomy Patients
Launched by JOHNS HOPKINS UNIVERSITY · Mar 21, 2025
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether using a custom-made prosthetic device can help prevent a condition called "Sunken Flap Syndrome" in patients who have had a type of surgery called decompressive craniectomy. This surgery is performed to relieve pressure on the brain when someone has experienced severe trauma, bleeding, or stroke. After such surgery, some patients may face problems like headaches, weakness, or even more serious issues because their brain doesn't have the protection of the skull. The trial aims to see if wearing the prosthetic can improve recovery, brain function, and potentially lower healthcare costs by reducing the need for additional medical visits.
To be eligible for this study, participants need to be adults over 18 who have had a decompressive craniectomy within the last two weeks and are being treated at Johns Hopkins Hospital or Johns Hopkins Bayview Medical Center. If someone decides to join the study and wear the prosthetic, they will receive it about four weeks after their surgery and will be asked to wear it as much as possible. Throughout the study, all participants will have regular check-ups to monitor their recovery and brain function, regardless of whether they wear the prosthetic or not. This research could provide valuable insights into improving care for patients recovering from serious brain injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18
- • Patients must be admitted to Johns Hopkins Hospital or Johns Hopkins Bayview Medical Center
- • Patients must have undergone decompressive hemicraniectomy within 2 weeks of consent for inclusion in the study (before the initial 2 week post-craniectomy assessment)
- Exclusion Criteria:
- • Patients that undergo bilateral decompressive hemicraniectomy
- • Patients that undergo suboccipital decompressive craniectomy
- • Patients with pre-existing diagnosis of hydrocephalus
- • Patients with a ventriculoperitoneal, ventriculoatrial, or other permanent cerebrospinal fluid shunt
- • Patients with an open external ventricular drain at the time of their 2 week post-craniectomy assessment
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Joseph M Dardick, MD
Principal Investigator
Johns Hopkins Medical Institute
Fernando Gonzalez, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported